395 related articles for article (PubMed ID: 1828347)
21. The paradox of 5-methoxy-N,N-dimethyltryptamine: an indoleamine hallucinogen that induces stimulus control via 5-HT1A receptors.
Winter JC; Filipink RA; Timineri D; Helsley SE; Rabin RA
Pharmacol Biochem Behav; 2000 Jan; 65(1):75-82. PubMed ID: 10638639
[TBL] [Abstract][Full Text] [Related]
22. 6-substituted tricyclic partial ergoline compounds are selective and potent 5-hydroxytryptamine1A receptor agents.
Slaughter JL; Harrington MA; Peroutka SJ
Life Sci; 1990; 47(15):1331-7. PubMed ID: 2172684
[TBL] [Abstract][Full Text] [Related]
23. Increase in serotonin 5-HT1A receptors in prefrontal and temporal cortices of brains from patients with chronic schizophrenia.
Hashimoto T; Nishino N; Nakai H; Tanaka C
Life Sci; 1991; 48(4):355-63. PubMed ID: 1824956
[TBL] [Abstract][Full Text] [Related]
24. Potential mechanisms involved in the negative coupling between serotonin 5-HT1A receptors and carbachol-stimulated phosphoinositide turnover in the rat hippocampus.
Claustre Y; Benavides J; Scatton B
J Neurochem; 1991 Apr; 56(4):1276-85. PubMed ID: 1848278
[TBL] [Abstract][Full Text] [Related]
25. Characterization of the aminomethylchroman derivative BAY x 3702 as a highly potent 5-hydroxytryptamine1A receptor agonist.
De Vry J; Schohe-Loop R; Heine HG; Greuel JM; Mauler F; Schmidt B; Sommermeyer H; Glaser T
J Pharmacol Exp Ther; 1998 Mar; 284(3):1082-94. PubMed ID: 9495870
[TBL] [Abstract][Full Text] [Related]
26. Biochemical evidence for the 5-HT agonist properties of PAT (8-hydroxy-2-(di-n-propylamino)tetralin) in the rat brain.
Hamon M; Bourgoin S; Gozlan H; Hall MD; Goetz C; Artaud F; Horn AS
Eur J Pharmacol; 1984 May; 100(3-4):263-76. PubMed ID: 6203761
[TBL] [Abstract][Full Text] [Related]
27. Do functional relationships exist between 5-HT1A and 5-HT2 receptors?
Darmani NA; Martin BR; Pandey U; Glennon RA
Pharmacol Biochem Behav; 1990 Aug; 36(4):901-6. PubMed ID: 2145593
[TBL] [Abstract][Full Text] [Related]
28. Pharmacological profile of (-)HT-90B, a novel 5-HT1A receptor agonist/5-HT2 receptor antagonist.
Uchida H; Inagawa K; Tameda C; Miyauchi T
Prog Neuropsychopharmacol Biol Psychiatry; 1995 Nov; 19(7):1201-16. PubMed ID: 8787043
[TBL] [Abstract][Full Text] [Related]
29. Thermoregulatory responses to serotonin (5-HT) receptor stimulation in the rat. Evidence for opposing roles of 5-HT2 and 5-HT1A receptors.
Gudelsky GA; Koenig JI; Meltzer HY
Neuropharmacology; 1986 Dec; 25(12):1307-13. PubMed ID: 2951611
[TBL] [Abstract][Full Text] [Related]
30. Serotonin-glutamate interaction in rat cerebellum: involvement of 5-HT1 and 5-HT2 receptors.
Maura G; Roccatagliata E; Ulivi M; Raiteri M
Eur J Pharmacol; 1988 Jan; 145(1):31-8. PubMed ID: 2965025
[TBL] [Abstract][Full Text] [Related]
31. 5-Hydroxytryptamine receptor agonists influence calcium-stimulated adenylate cyclase activity in the cerebral cortex and hippocampus of the rat.
Mørk A; Geisler A
Eur J Pharmacol; 1990 Jan; 175(3):237-44. PubMed ID: 2138981
[TBL] [Abstract][Full Text] [Related]
32. Pharmacological characterization of serotonin receptor subtypes involved in vasopressin and plasma renin activity responses to serotonin agonists.
Bagdy G; Sved AF; Murphy DL; Szemeredi K
Eur J Pharmacol; 1992 Jan; 210(3):285-9. PubMed ID: 1535317
[TBL] [Abstract][Full Text] [Related]
33. Activity of serotonin (5-HT) receptor agonists, partial agonists and antagonists at cloned human 5-HT1A receptors that are negatively coupled to adenylate cyclase in permanently transfected HeLa cells.
Pauwels PJ; Van Gompel P; Leysen JE
Biochem Pharmacol; 1993 Jan; 45(2):375-83. PubMed ID: 8382063
[TBL] [Abstract][Full Text] [Related]
34. 5-HT1A-receptors mediate stimulation of adenylate cyclase in rat hippocampus.
Markstein R; Hoyer D; Engel G
Naunyn Schmiedebergs Arch Pharmacol; 1986 Aug; 333(4):335-41. PubMed ID: 2945992
[TBL] [Abstract][Full Text] [Related]
35. Pharmacological characterization of the 5-HT1A, 5-HT2 and 5-HT3 receptors in the bovine ciliary muscle.
Lograno MD; Romano MR
Eur J Pharmacol; 2003 Mar; 464(1):69-74. PubMed ID: 12600697
[TBL] [Abstract][Full Text] [Related]
36. Interactions of (+)- and (-)-8- and 7-hydroxy-2-(di-n-propylamino)tetralin at human (h)D3, hD2 and h serotonin1A receptors and their modulation of the activity of serotoninergic and dopaminergic neurones in rats.
Lejeune F; Newman-Tancredi A; Audinot V; Millan MJ
J Pharmacol Exp Ther; 1997 Mar; 280(3):1241-9. PubMed ID: 9067310
[TBL] [Abstract][Full Text] [Related]
37. Destruction of the nucleus raphe obscurus and potentiation of serotonin-mediated behaviors following administration of the neurotoxin 3-acetylpyridine.
Wieland S; Kreider MS; McGonigle P; Lucki I
Brain Res; 1990 Jun; 520(1-2):291-302. PubMed ID: 1698505
[TBL] [Abstract][Full Text] [Related]
38. Differentiation of pre- and post-synaptic high affinity serotonin receptor binding sites using physico-chemical parameters and modifying agents.
Hall MD; Gozlan H; Emerit MB; el Mestikawy S; Pichat L; Hamon M
Neurochem Res; 1986 Jun; 11(6):891-912. PubMed ID: 3016581
[TBL] [Abstract][Full Text] [Related]
39. Evidence that the hyperphagic response to 8-OH-DPAT is mediated by 5-HT1A receptors.
Hutson PH; Dourish CT; Curzon G
Eur J Pharmacol; 1988 Jun; 150(3):361-6. PubMed ID: 2970974
[TBL] [Abstract][Full Text] [Related]
40. Role of 5-hydroxytryptamine receptors on luteinizing-hormone-releasing hormone release in the ovariectomized, estradiol-treated rat.
Meyer DC; McRee C; Jacobs M
Brain Res Bull; 1992 Jun; 28(6):853-60. PubMed ID: 1386277
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
